Cancer Blog
- Dr. Robert Nagourney -

Treatments should really be given more selectively, i.e. “give this chemotherapy only to those people who will benefit from it,” She said.

Rising corporate influence and focus on reimbursement in medicine now discourage doctors from straying from strict treatment guidelines.

Despite advances in breast cancer management, we must all recognize that every patient is unique and their treatments should be too.

With the explosion of immunotherapy in oncology, the checkpoint inhibitors (Pembrolizumab, Nivolumab, Ipililumab, etc.) are being used in...